Skip to main content

Closed

BDSX: Biodesix, Inc. Stock Analysis | finqOS

Healthcare · Medical - Diagnostics & Research

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth+45.3% / yr

Operating margin-25.9%

ROIC-30.5%

Financially safe

Stretched

Debt / equity7.84×

Interest coverage-3.1×

Current ratio2.82×

Biodesix, Inc.

BDSXNASDAQ Global Market·USD·Closed

Biodesix, Inc.

BDSXNASDAQ·USD·Closed

$21.20

−0.63%

$21.20

−$0.14 (0.63%)

52W Range

81thpctl

Volume

0.54×avg

Mkt Cap

172.57MUSD

P/E

-5.3TTM

Div Yield

–ann

52W Range

81thpctl

Volume

0.54×avg

Market Cap

172.57MUSD

P/E Ratio

-5.3TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings